AmericaFirst Defensive Growth & Income Portfolio Series 2’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
$303K Buy
+9,110
New +$303K 0.38% 89